Tamoxifen, a widely used hormone therapy medication for breast cancer, is associated with a slightly increased risk of developing endometrial cancer. However, this risk is generally considered low. It is crucial to discuss the benefits and risks of tamoxifen with your doctor, who can provide personalized guidance regarding your treatment.